Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03049813 · ClinicalTrials.gov registry record · NA
Virtual Reality Job Interview Training in Severe Mental Illness
A NA study of Schizophrenia and Bipolar Disorder, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 168
- Enrollment target
- 4
- Study locations
NCT03049813: Completed NA study of Schizophrenia and Bipolar Disorder, sponsored by University of Michigan.
NCT03049813 is a NA study of Schizophrenia and Bipolar Disorder that has completed, run by University of Michigan. The registered enrollment target is 168 participants, below the 218-participant average among 315 other Schizophrenia trials with a reported enrollment target (23% lower). The trial reports 4 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03049813, a NA study of Schizophrenia and Bipolar Disorder, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 168 participants
- Enrollment target
- 4
- Study locations
Study Summary
This is a randomized controlled trial to evaluate the community-based effectiveness of virtual reality job interview training (VR-JIT). Northwestern University is partnering with Thresholds Inc. to evaluate the effectiveness of VR-JIT at improving interviewing skills and access to employment. In addition, we will evaluate the cost effectiveness of VR-JIT and the process for implementing VR-JIT at Thresholds.
Primary Outcome
Employment rates at 9-month follow-up visit measured with questionnaire.
Conditions Studied
Interventions
- BEHAVIORAL Virtual Reality Job Interview Training
- OTHER Supported Employment (Services as Usual)
Study Locations (4)
Illinois
- Thresholds Bridge South - Chicago
- Thresholds Ogden - Chicago
- Thresholds Bridge Southwest - Chicago
- Thresholds Bridge West - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 168 participants |
| Start Date | 2017-06-01 |
| Est. Completion | 2022-07-31 |
| Phase | NA |
What the finished NCT03049813 record still lists
NCT03049813 is an interventional study that assigns participants to a tested intervention. The registered 168 participants enrollment target is mid-sized for trials with a published cap, below the 218-participant average among 315 other Schizophrenia trials with a reported enrollment target (23% lower).
The record links to 4 conditions, with Schizophrenia appearing as the primary indexed condition, and to 2 interventions - of which Virtual Reality Job Interview Training is the first listed.
NCT03049813 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT03049813 about?
NCT03049813 is a clinical study titled "Virtual Reality Job Interview Training in Severe Mental Illness". This is a randomized controlled trial to evaluate the community-based effectiveness of virtual reality job interview training (VR-JIT). Northwestern University is partnering with Thresholds Inc. to evaluate the effectiveness of VR-JIT at improving interviewing skills and access to employment. In add...
What is the current status of trial NCT03049813?
This trial is currently completed. It is a NA study. The enrollment target is 168 participants. The study started on 2017-06-01. Estimated completion is 2022-07-31.
What conditions does trial NCT03049813 study?
This clinical trial studies the following conditions: Schizophrenia, Bipolar Disorder, Schizoaffective Disorder, Depressive Disorder.
What interventions are being tested in trial NCT03049813?
The interventions under investigation include: Virtual Reality Job Interview Training (BEHAVIORAL), Supported Employment (Services as Usual) (OTHER).
Who is sponsoring clinical trial NCT03049813?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03049813 being conducted?
This trial has 4 study locations across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Schizophrenia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03049813's enrollment target sits among peer trials
168 96th of 315 higher than 220 of 315 other Schizophrenia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Schizophrenia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Taking Action for College Students
RECRUITING · NA
-
Enhancing Prefrontal Oscillations and Working Memory in Early-course Schizophrenia
RECRUITING · NA
-
Getting Out of the House: Using Behavioral Activation to Increase Community Participation
RECRUITING · NA
-
Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 1)
RECRUITING · NA
-
Cerebellar Modulation of Cognition in Psychosis
RECRUITING · NA
-
TMS for Inhibition Enhancement in Schizophrenia
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02118922 · 168 participants
A Study to Test the Diagnostic Potential of Brillouin Microscopy for Corneal Ectasia
- NCT03536897 · 168 participants
IORT Following Breast Conserving Surgery for Early Stage Breast Cancer Registry
- NCT04078230 · 168 participants · NA
Regional or Extend LymphAdenectomy During Resection of Intrahepatic Cholangiocarcinoma
- NCT04159168 · 168 participants · NA
Facial Affect Sensitivity Training for Young Children With Callous-unemotional Traits
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI